SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 246 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $486,000 | +27.9% | 20,502 | -3.0% | 0.07% | -2.9% |
| Q1 2020 | $380,000 | -46.3% | 21,127 | -29.2% | 0.07% | -33.7% |
| Q4 2019 | $708,000 | -34.0% | 29,850 | -23.5% | 0.10% | -40.9% |
| Q3 2019 | $1,072,000 | -28.1% | 39,023 | -13.3% | 0.18% | -29.9% |
| Q2 2019 | $1,490,000 | -4.7% | 45,033 | +0.9% | 0.25% | -8.1% |
| Q1 2019 | $1,563,000 | +24.7% | 44,613 | +18.2% | 0.27% | +5.4% |
| Q4 2018 | $1,253,000 | -40.2% | 37,739 | -9.3% | 0.26% | -31.7% |
| Q3 2018 | $2,096,000 | – | 41,630 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |